Skip to main content

Table 4 Reducing effect of EAA/KA on GFR slope decrease: the results of uni-variate analysis, categorical variable comparison and variables in final multi-variate model

From: Efficacy of the Essential Amino Acids and Keto-Analogues on the CKD progression rate in real practice in Russia - city nephrology registry data for outpatient clinic

  Uni-variate analysis Final model of multi-variate analysisb
Variable Unstandardized B p 95 % CI for B Unstandardized B p 95 % CI for B
Age (per 10 year) 0.023 0.08 −0.004 ÷ 0.05 0.021 0.06 −0.002 ÷ 0.04
PU mean (per 1 g/day) −0.061 0.08 −0.13 ÷ 0.09 −0.065 0.06 −0.14 ÷ 0.005
PU max (per 1 g/day) −0.023 0.38 −0.004 ÷ 0.05
Albumin (per 0.1 g/dl) −0.061 0.21 −0.04 ÷ 0.16
Phosphate (per 0.1 mmol/l) 0.015 0.18 −0.008 ÷ 0.04 0.016 0.08 −0.003 ÷ 0.03
Hb (per 1 g/dl) 0.018 0.32 −0.02 ÷ 0.06
ln CRP (per 0.1 mg/dla) −0.039 0.14 −0.09 ÷ 0.15
Categorical variable comparisons Categorical variable in equation
 Glom. v. interst. −0.082 ± 0.035 0.06 −0.059 ± 0.044 −0.016 0.06 −0.003 ÷ 0.03
 Female v. male −0.079 ± 0.025 0.11 −0.066 ± 0.024 −0.013 0.03 −0.003 ÷ − 0.001
 DM v. non-DM −0.072 ± 0.021 0.50 −0.069 ± 0.023
  1. CI confidence interval, PU proteinuria, g/day, mean averaged for study period, max maximum per study period, Hb hemoglobin, CRP C-reactive protein, glom. glomerular diseases, interst. interstitial diseases, DM diabetes mellitus
  2. aBefore ln-transformation
  3. bp for exclusion from model 0.10